| Nome |
# |
|
Primary hyperparathyroidism, file e0d6c92d-2bdb-fcf8-e053-d805fe0aa794
|
348
|
|
Clinical presentation and management of patients with primary hyperparathyroidism in Italy, file e0d6c92b-9f68-fcf8-e053-d805fe0aa794
|
322
|
|
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation, file e0d6c92c-7604-fcf8-e053-d805fe0aa794
|
111
|
|
Italian association of clinical endocrinologists (AME) position statement: drug therapy of osteoporosis, file e0d6c92d-2be1-fcf8-e053-d805fe0aa794
|
107
|
|
Calcifediol Rather Than Cholecalciferol for a Patient Submitted to Malabsortive Bariatric Surgery: A Case Report, file e0d6c92d-2446-fcf8-e053-d805fe0aa794
|
104
|
|
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features, file e0d6c92b-0abb-fcf8-e053-d805fe0aa794
|
103
|
|
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement, file e0d6c92c-c2b2-fcf8-e053-d805fe0aa794
|
93
|
|
null, file e0d6c92c-d1be-fcf8-e053-d805fe0aa794
|
80
|
|
Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves [Surgical complications in orbital decompression for Graves’ orbitopathy], file e0d6c928-0187-fcf8-e053-d805fe0aa794
|
72
|
|
null, file e0d6c92b-f771-fcf8-e053-d805fe0aa794
|
48
|
|
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4), file e0d6c92d-2be4-fcf8-e053-d805fe0aa794
|
43
|
|
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade, file e0d6c932-4016-fcf8-e053-d805fe0aa794
|
32
|
|
Circulating long non-coding rna gas5 is overexpressed in serum from osteoporotic patients and is associated with increased risk of bone fragility, file e0d6c931-5373-fcf8-e053-d805fe0aa794
|
23
|
|
Thyroid volume and severity of graves' orbitopathy, file e0d6c926-d860-fcf8-e053-d805fe0aa794
|
22
|
|
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade, file d798a6dc-94ad-4945-8520-429b5c23639f
|
15
|
|
Endoscopic parathyroidectomy: report of an initial experience, file e0d6c926-1288-fcf8-e053-d805fe0aa794
|
12
|
|
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts, file e0d6c926-d374-fcf8-e053-d805fe0aa794
|
11
|
|
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade, file e0d6c931-4554-fcf8-e053-d805fe0aa794
|
11
|
|
Vitamin D measurement and effect on outcome in a cohort of patients with heart failure, file ba765350-fbbd-454c-9384-b736c343388d
|
8
|
|
Teprotumumab for the Treatment of Active Thyroid Eye Disease, file e0d6c92e-82c7-fcf8-e053-d805fe0aa794
|
8
|
|
Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy, file e0d6c92e-cfb3-fcf8-e053-d805fe0aa794
|
7
|
|
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial, file e0d6c926-d0f9-fcf8-e053-d805fe0aa794
|
6
|
|
No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas, file e0d6c926-24c6-fcf8-e053-d805fe0aa794
|
5
|
|
Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study, file e0d6c92a-71f5-fcf8-e053-d805fe0aa794
|
5
|
|
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment?, file e0d6c92d-1771-fcf8-e053-d805fe0aa794
|
5
|
|
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism, file e0d6c931-8cdc-fcf8-e053-d805fe0aa794
|
5
|
|
TSH suppressive therapy and bone, file e0d6c931-a6cc-fcf8-e053-d805fe0aa794
|
5
|
|
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival, file e0d6c928-e62c-fcf8-e053-d805fe0aa794
|
4
|
|
Occurrence of Graves’ Orbitopathy and of Graves’ hyperthyroidism after a trauma to the eye, file e0d6c92c-bd41-fcf8-e053-d805fe0aa794
|
4
|
|
Measurement of urinary free cortisol by LC–MS–MS: adoption of a literature reference range and comparison with our current immunometric method. (Saba A., Agretti P., co-last authors), file e0d6c92d-3fad-fcf8-e053-d805fe0aa794
|
4
|
|
Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis, file e0d6c931-aad8-fcf8-e053-d805fe0aa794
|
4
|
|
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells, file e0d6c926-1d9b-fcf8-e053-d805fe0aa794
|
3
|
|
Different somatic alterations of the HRPT2 gene in a patient with recurrent
sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation, file e0d6c926-2de8-fcf8-e053-d805fe0aa794
|
3
|
|
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma, file e0d6c927-3a84-fcf8-e053-d805fe0aa794
|
3
|
|
Mechanistic Pathways of Selenium in the Treatment of Graves' Disease and Graves' Orbitopathy, file e0d6c92c-b81c-fcf8-e053-d805fe0aa794
|
3
|
|
Natural history of graves’ orbitopathy after treatment, file e0d6c92d-0d53-fcf8-e053-d805fe0aa794
|
3
|
|
Do the heterozygous carriers of a CYP24A1 mutation display a different biochemical phenotype than wild types?, file e0d6c92f-7a5e-fcf8-e053-d805fe0aa794
|
3
|
|
First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation., file e0d6c926-4620-fcf8-e053-d805fe0aa794
|
2
|
|
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited., file e0d6c926-d224-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92c-69d1-fcf8-e053-d805fe0aa794
|
2
|
|
Use of low-dose radioiodine ablation for Gravesâ orbitopathy: results of a pilot, perspective study in a small series of patients, file e0d6c92c-bd90-fcf8-e053-d805fe0aa794
|
2
|
|
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial, file e0d6c92c-bf5e-fcf8-e053-d805fe0aa794
|
2
|
|
Novel association of MEN1 gene mutations with parathyroid carcinoma, file e0d6c92c-e097-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92c-e4b2-fcf8-e053-d805fe0aa794
|
2
|
|
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center, file e0d6c92c-e4b5-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92c-fa8e-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-02cd-fcf8-e053-d805fe0aa794
|
2
|
|
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY, file e0d6c92d-1cc1-fcf8-e053-d805fe0aa794
|
2
|
|
null, file e0d6c92d-2618-fcf8-e053-d805fe0aa794
|
2
|
|
Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism, file e0d6c92e-b3fc-fcf8-e053-d805fe0aa794
|
2
|
|
Do the heterozygous carriers of a CYP24A1 mutation display a different biochemical phenotype than wild types?, file e0d6c930-78d3-fcf8-e053-d805fe0aa794
|
2
|
|
Oxidative Stress in Graves Disease and Graves Orbitopathy, file e0d6c931-3d34-fcf8-e053-d805fe0aa794
|
2
|
|
Graves’ disease and Graves’ orbitopathy following COVID-19, file e0d6c931-5ec1-fcf8-e053-d805fe0aa794
|
2
|
|
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic, file e0d6c931-5ecb-fcf8-e053-d805fe0aa794
|
2
|
|
Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study, file e0d6c931-687e-fcf8-e053-d805fe0aa794
|
2
|
|
Beneficial effect of low-dose radioiodine ablation for Graves’ orbitopathy: results of a retrospective study, file e0d6c931-99f0-fcf8-e053-d805fe0aa794
|
2
|
|
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study, file e0d6c931-d2cd-fcf8-e053-d805fe0aa794
|
2
|
|
Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism, file b100750b-3873-42fa-bb6e-cc49d80f551d
|
1
|
|
Direct determination of the radio of tetrahydrocortisol + allo- tetrahydrocortisol to tetrahydrocortisone in urine by LC-MS-MS, file e0d6c92a-321a-fcf8-e053-d805fe0aa794
|
1
|
|
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis, file e0d6c92c-8e75-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-d1ba-fcf8-e053-d805fe0aa794
|
1
|
|
Selenium in the Treatment of Thyroid Diseases, file e0d6c92c-e0a0-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-e210-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-e22a-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-e4b0-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92c-ea8d-fcf8-e053-d805fe0aa794
|
1
|
|
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients, file e0d6c92d-09a1-fcf8-e053-d805fe0aa794
|
1
|
|
Clinical profile of juvenile primary hyperparathyroidism: a prospective study, file e0d6c92d-09ad-fcf8-e053-d805fe0aa794
|
1
|
|
A 2016 Italian Survey about the Clinical Use of Selenium in Thyroid Disease, file e0d6c92d-1cc0-fcf8-e053-d805fe0aa794
|
1
|
|
null, file e0d6c92d-2f04-fcf8-e053-d805fe0aa794
|
1
|
|
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature, file e0d6c92e-4466-fcf8-e053-d805fe0aa794
|
1
|
|
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study, file e0d6c931-9d6f-fcf8-e053-d805fe0aa794
|
1
|
|
Role of the mononuclear cell infiltrate in Graves’ orbitopathy (GO): results of a large cohort study, file e0d6c931-eec1-fcf8-e053-d805fe0aa794
|
1
|
| Totale |
1.701 |